Cite
MLA Citation
Robin Kate Kelley et al.. “Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.” Journal of clinical oncology, vol. 39, no. 27, 2021, pp. 2991–3001. http://access.bl.uk/ark:/81055/vdc_100150610061.0x000032